Published in Medicine (Baltimore) on April 01, 2017
The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol (2006) 25.47
Physician recommendations and patient autonomy: finding a balance between physician power and patient choice. Ann Intern Med (1996) 6.56
Effect of cost sharing on screening mammography in Medicare health plans. N Engl J Med (2008) 4.48
Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology (2005) 3.37
Elephant medicine revisited. Tex Heart Inst J (2008) 1.94
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology (2007) 1.71
The role of physicians' recommendations in medical treatment decisions. Med Decis Making (2002) 1.70
Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects. Ophthalmologica (1998) 1.45
Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population. Med Care (1999) 1.40
What influences participation in genetic carrier testing? Results from a discrete choice experiment. J Health Econ (2005) 1.22
Novel drug delivery systems for glaucoma. Eye (Lond) (2011) 1.00
A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine. Biomaterials (2011) 0.97
Estimating older adults' preferences for walking programs via conjoint analysis. Am J Prev Med (2009) 0.94
Stagnation and herd mentality in the biomedical sciences. Cancer Biol Ther (2004) 0.91
Gallic acid grafting effect on delivery performance and antiglaucoma efficacy of antioxidant-functionalized intracameral pilocarpine carriers. Acta Biomater (2016) 0.80
Herd mentality. BMJ (2011) 0.79
Measuring High-Risk Patients' Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction: A Discrete Choice Experiment. Value Health (2016) 0.79
Effects of simplifying choice tasks on estimates of taste heterogeneity in stated-choice surveys. Soc Sci Med (2009) 0.78
Providing Informal Care in Terminal Illness: An Analysis of Preferences for Support Using a Discrete Choice Experiment. Med Decis Making (2013) 0.78
Environment, obesity, and cardiovascular disease risk in low-income women. Am J Prev Med (2006) 2.39
Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) (2008) 2.23
Cost effectiveness of internet interventions: review and recommendations. Ann Behav Med (2009) 2.21
Medical costs and productivity losses due to interpersonal and self-directed violence in the United States. Am J Prev Med (2007) 2.15
Cancer treatment cost in the United States: has the burden shifted over time? Cancer (2010) 2.10
Effect of a stepped-care intervention approach on weight loss in adults: a randomized clinical trial. JAMA (2012) 2.02
Public perceptions of childhood obesity. Am J Prev Med (2005) 1.85
Considerations for an obesity policy research agenda. Am J Prev Med (2009) 1.57
Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study. Clin Experiment Ophthalmol (2012) 1.57
Postoperative complications after glaucoma surgery for primary angle-closure glaucoma vs primary open-angle glaucoma. Arch Ophthalmol (2011) 1.55
State-level Medicaid expenditures attributable to smoking. Prev Chronic Dis (2009) 1.50
The economic burden of chronic cardiovascular disease for major insurers. Health Promot Pract (2007) 1.49
Return on investment for bariatric surgery. Am J Manag Care (2008) 1.48
State- and payer-specific estimates of annual medical expenditures attributable to obesity. Obesity (Silver Spring) (2011) 1.47
Youth BMI trajectories: evidence from the NLSY97. Obesity (Silver Spring) (2009) 1.36
Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. Mol Vis (2012) 1.26
Estimates of state-level health-care expenditures associated with disability. Public Health Rep (2010) 1.25
Use of econometric models to estimate expenditure shares. Health Serv Res (2008) 1.20
Beyond effectiveness: evaluating the public health impact of the WISEWOMAN program. Am J Public Health (2007) 1.17
Health promotion interventions for disadvantaged women: overview of the WISEWOMAN projects. J Womens Health (Larchmt) (2004) 1.16
Young adult weight trajectories through midlife by body mass category. Obesity (Silver Spring) (2013) 1.15
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung. Cancer (2011) 1.10
Comparing cost-of-illness estimates from alternative approaches: an application to diabetes. Health Serv Res (2009) 1.08
Confirmation of the presence of uveal effusion in Asian eyes with primary angle closure glaucoma: an ultrasound biomicroscopy study. Arch Ophthalmol (2008) 1.07
The NEIGHBOR consortium primary open-angle glaucoma genome-wide association study: rationale, study design, and clinical variables. J Glaucoma (2013) 1.06
Insurance coverage and incentives for weight loss among adults with metabolic syndrome. Obesity (Silver Spring) (2008) 1.02
Spatial analysis of body mass index and smoking behavior among WISEWOMAN participants. J Womens Health (Larchmt) (2004) 1.00
Methods for estimating medical expenditures attributable to intimate partner violence. J Interpers Violence (2008) 1.00
Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial. Trials (2014) 0.96
Increased SPARC expression in primary angle closure glaucoma iris. Mol Vis (2008) 0.96
Calcium-binding S100 protein expression in pterygium. Mol Vis (2009) 0.95
A cluster randomised controlled trial evaluating an incentive-based outdoor physical activity programme to increase outdoor time and prevent myopia in children. Ophthalmic Physiol Opt (2014) 0.94
Biocompatibility and biodegradation studies of subconjunctival implants in rabbit eyes. PLoS One (2011) 0.94
Estimating older adults' preferences for walking programs via conjoint analysis. Am J Prev Med (2009) 0.94
SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery. PLoS One (2010) 0.92
A return-on-investment simulation model of workplace obesity interventions. J Occup Environ Med (2009) 0.91
Aberrant DNA methylation of matrix remodeling and cell adhesion related genes in pterygium. PLoS One (2011) 0.89
Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci (2009) 0.88
Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing. Small (2014) 0.87
Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year. Clin Experiment Ophthalmol (2013) 0.87
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye. Int J Nanomedicine (2012) 0.87
Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye. PLoS One (2011) 0.86
In vitro analyses of the anti-fibrotic effect of SPARC silencing in human Tenon's fibroblasts: comparisons with mitomycin C. J Cell Mol Med (2012) 0.86
Optimization of subconjunctival biodegradable microfilms for sustained drug delivery to the anterior segment in a small animal model. Invest Ophthalmol Vis Sci (2013) 0.85
Evaluation of sustained release of PLC-loaded prednisolone acetate microfilm on postoperative inflammation in an experimental model of glaucoma filtration surgery. Curr Eye Res (2011) 0.85
Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma. ACS Nano (2014) 0.85
Tear cytokine profile in medicated glaucoma patients: effect of monocyte chemoattractant protein 1 on early posttrabeculectomy outcome. Ophthalmology (2010) 0.84
The Singapore 5-fluorouracil trial: intraocular pressure outcomes at 8 years. Ophthalmology (2013) 0.84
Outcomes of trabeculectomy after descemet stripping automated endothelial keratoplasty: a comparison with penetrating keratoplasty. Am J Ophthalmol (2012) 0.84
The impact of medication use in a multicomponent intervention: results from the WISEWOMAN program. Am J Health Promot (2007) 0.84
The effect of weight loss on health, productivity, and medical expenditures among overweight employees. Med Care (2013) 0.82
A biodegradable, sustained-released, prednisolone acetate microfilm drug delivery system effectively prolongs corneal allograft survival in the rat keratoplasty model. PLoS One (2013) 0.82
Identification and characterization of mesenchymal stem cells derived from the trabecular meshwork of the human eye. Stem Cells Dev (2012) 0.82
Validation of the glaucoma filtration surgical mouse model for antifibrotic drug evaluation. Mol Med (2011) 0.81
Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study. Contemp Clin Trials (2013) 0.80
Involvement of SPARC and MMP-3 in the pathogenesis of human pterygium. Invest Ophthalmol Vis Sci (2012) 0.80
De novo ocular hypertension after Descemet stripping endothelial keratoplasty: comparative 3-year incidence, risk factors, and outcomes. Clin Ophthalmol (2013) 0.79
Motivation for participating in a weight loss program and financial incentives: an analysis from a randomized trial. J Obes (2012) 0.79
Use of behavior change techniques in clean cooking interventions: a review of the evidence and scorecard of effectiveness. J Health Commun (2015) 0.77
Hevin plays a pivotal role in corneal wound healing. PLoS One (2013) 0.77
Intraocular lens as a drug delivery reservoir. Curr Opin Ophthalmol (2013) 0.77
Impact of bilateral open and closed-angle glaucoma on glaucoma-specific functioning in Asians. J Glaucoma (2013) 0.77
A biodegradable ocular implant for long-term suppression of intraocular pressure. Drug Deliv Transl Res (2015) 0.77
Acceptance, attitudes, and beliefs of Singaporean Chinese toward an ocular implant for glaucoma drug delivery. Invest Ophthalmol Vis Sci (2012) 0.77
Patient acceptance and attitude toward an alternative method of subconjunctival injection for the medical treatment of glaucoma. J Glaucoma (2013) 0.77
Knowledge and perceptions among overweight and obese employees about lifestyle-related health benefit changes. N C Med J (2011) 0.75
Prevalence of comorbidities and baseline characteristics of LAP-BAND AP® subjects in the Helping Evaluate Reduction in Obesity (HERO) study. PLoS One (2013) 0.75
Cost Minimization Analysis of Precut Cornea Grafts in Descemet Stripping Automated Endothelial Keratoplasty. Medicine (Baltimore) (2016) 0.75
A new design and application of bioelastomers for better control of intraocular pressure in a glaucoma drainage device. Adv Healthc Mater (2013) 0.75
A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes. J Glaucoma (2015) 0.75
A comparison of applanation tonometry using conventional reusable goldmann prisms and disposable prisms. J Glaucoma (2014) 0.75
Control of blood pressure and risk attenuation: a public health intervention in rural Bangladesh, Pakistan, and Sri Lanka: feasibility trial results. J Hypertens (2016) 0.75
A practical model for economic evaluation of tissue-engineered therapies. Wiley Interdiscip Rev Syst Biol Med (2015) 0.75
Recall of three heart disease risk factor diagnoses among low-income women. J Womens Health (Larchmt) (2009) 0.75